SOPHNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
SOPHiA GENETICS SA
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 3, 2026
$6.49−0.24 (-3.57%)
Close on Oct 19, 2026
- Market cap
- $479.21M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2018 to 2025
Gross margin
67.4%+5.1 pts over 5 years
Operating margin
-91.8%+39.9 pts over 5 years
Net margin
-102.2%+36.3 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +18.6% | +17.6% | +22.2% | – | |
| Gross profit | +18.5% | +18.6% | +24.1% | – |
Returns and balance sheet
8 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2018 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on assets | – | – | -49.6% | |
| Current ratio | – | 5.08 | 1.96 | |
| Interest coverage | – | -44.5× | -15.6× | |
| Inventory turnover | – | – | 4.1× | |
| Capex to revenue | – | 1.6% | 0.7% | |
| Diluted shares | – | 42M | 68M |
Where the cash went
Fiscal 2021 to 2025, five years combined
SOPHiA GENETICS generated $261.66M from operations and spent $9.09M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$261.66M
Used
$9.09M
Capital expenditure$9.09M100%Dividends$00%Share buybacks$00%
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
2of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$79.00M
- Cash generatingOperating cash flow above zero-$35.89M
- Return on assets improvedROA up on the prior year-30.3% → -50.9%
- Earnings backed by cashOperating cash flow above net income-$35.89M vs -$79.00M
- Less leverageLong-term debt to assets fell8.5% → 29.3%
- Better liquidityCurrent ratio rose3.71 → 1.96
- No dilutionShare count did not rise66M → 68M
- Gross margin improvedGross margin up on the prior year67.42% → 67.40%
- More efficientAsset turnover rose0.32 → 0.50